Targeted Delivery of Liposomal Temozolomide Enhanced Anti-Glioblastoma Efficacy through Ultrasound-Mediated Blood-Brain Barrier Opening

Glioblastoma (GBM) is the commonest form of primary brain tumor in the central nervous system, with median survival below 15 months and only a 25% two-year survival rate for patients. One of the major clinical challenges in treating GBM is the presence of the blood-brain barrier (BBB), which greatly...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhuqing Song (Author), Xiuxian Huang (Author), Jieqiong Wang (Author), Feiyan Cai (Author), Ping Zhao (Author), Fei Yan (Author)
Format: Book
Published: MDPI AG, 2021-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!